Monday, July 27, 2009

Amgen, GSK to Launch Joint Sales Attack for Bone Drug

Glaxo will pay the biotech $120 million and royalties in commercialization efforts for denosumab.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)